Free Trial

Relay Therapeutics (RLAY) SEC Filings & 10K Form

Relay Therapeutics logo
$4.16 -0.10 (-2.35%)
(As of 12/20/2024 05:45 PM ET)

Recent Relay Therapeutics SEC Filings

DateFilerForm TypeView
12/16/2024
3:18 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
6:00 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:10 PM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:07 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:08 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:09 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:09 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:05 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:45 PM
Relay Therapeutics (Filer)
Form 424B5
09/11/2024
3:49 PM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:43 PM
Relay Therapeutics (Filer)
Form 424B5
09/09/2024
7:00 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
4:23 PM
Relay Therapeutics (Filer)
Form S-3ASR
08/06/2024
3:15 PM
Relay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
5:42 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:42 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:43 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:43 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:06 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
5:37 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2024
3:24 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
3:29 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/26/2024
3:47 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
3:05 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:15 PM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
3:38 PM
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:41 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:41 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:42 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:43 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:18 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2024
7:00 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
7:01 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:02 PM
HILL LINDA A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:03 PM
Borisy Alexis (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:03 PM
INGRAM DOUGLAS S (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:04 PM
Kathiresan Sekar (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:04 PM
Relay Therapeutics (Issuer)
Rubin Jami (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:05 PM
Relay Therapeutics (Issuer)
Shawver Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:05 PM
Murcko Mark (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:12 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry. 
05/02/2024
3:15 PM
Relay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
7:30 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:31 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:33 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:36 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:05 PM
Relay Therapeutics (Filer)
Form DEF 14A
04/23/2024
3:10 PM
Relay Therapeutics (Filer)
Form DEFA14A
04/23/2024
3:15 PM
Relay Therapeutics (Filer)
Form ARS
03/29/2024
3:15 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:15 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:15 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:15 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
3:34 PM
Relay Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
3:16 PM
Relay Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/31/2024
3:11 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
8:35 AM
Relay Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/18/2024
3:25 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:10 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:13 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:16 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:19 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
8:22 AM
Relay Therapeutics (Filer)
Form 424B7
01/10/2024
8:14 AM
Relay Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/08/2024
6:05 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
3:22 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
3:26 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
3:14 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
3:17 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RLAY) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners